Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy

  • Nico C Grossmann (Geteilte/r Erstautor/in)
  • Victor M Schuettfort (Geteilte/r Erstautor/in)
  • Benjamin Pradere
  • Pawel Rajwa
  • Fahad Quhal
  • Hadi Mostafaei
  • Ekaterina Laukhtina
  • Keiichiro Mori
  • Reza S Motlagh
  • Abdulmajeed Aydh
  • Satoshi Katayama
  • Marco Moschini
  • Christian D Fankhauser
  • Thomas Hermanns
  • Mohammad Abufaraj
  • Dong-Ho Mun
  • Kristin Zimmermann
  • Harun Fajkovic
  • Martin Haydter
  • Shahrokh F Shariat

Beteiligte Einrichtungen

Abstract

PURPOSE: To investigate the predictive and prognostic value of the preoperative systemic immune-inflammation index (SII) in patients undergoing radical cystectomy (RC) for clinically non-metastatic urothelial cancer of the bladder (UCB).

METHODS: Overall, 4,335 patients were included, and the cohort was stratified in two groups according to SII using an optimal cut-off determined by the Youden index. Uni- and multivariable logistic and Cox regression analyses were performed, and the discriminatory ability by adding SII to a reference model based on available clinicopathologic variables was assessed by area under receiver operating characteristics curves (AUC) and concordance-indices. The additional clinical net-benefit was assessed using decision curve analysis (DCA).

RESULTS: High SII was observed in 1879 (43%) patients. On multivariable preoperative logistic regression, high SII was associated with lymph node involvement (LNI; P = 0.004), pT3/4 disease (P <0.001), and non-organ confined disease (NOCD; P <0.001) with improvement of AUCs for predicting LNI (P = 0.01) and pT3/4 disease (P = 0.01). On multivariable Cox regression including preoperative available clinicopathologic values, high SII was associated with recurrence-free survival (P = 0.028), cancer-specific survival (P = 0.005), and overall survival (P = 0.006), without improvement of concordance-indices. On DCAs, the inclusion of SII did not meaningfully improve the net-benefit for clinical decision-making in all models.

CONCLUSION: High preoperative SII is independently associated with pathologic features of aggressive disease and worse survival outcomes. However, it did not improve the discriminatory margin of a prediction model beyond established clinicopathologic features and failed to add clinical benefit for decision making. The implementation of SII as a part of a panel of biomarkers in future studies might improve decision-making.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1078-1439
DOIs
StatusVeröffentlicht - 03.2022

Anmerkungen des Dekanats

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

PubMed 34810077